Guyana: Frontera Energy releases independent Resource Evaluation for Guyana Blocks
16 Feb 2021 independent Prospective Resource study and report in respect of the
Corentyne North Area, Corentyne Main Area and Demerara block, offshore Guyana. The Joint Venture has also announced the successful rescheduling of the Joint Venture s work commitments with respect to its
Petroleum Prospecting License ( PPL ) for the Demerara block offshore Guyana. We thank the Government of Guyana for its continued support and partnership, which are essential to the long-term success of this strategic initiative for the benefit of all stakeholders. said Gabriel De Alba Chairman of the Board of Directors.
Kiklabb, the Dubai Government-owned licensing solutions, now accepts cryptocurrencies as a payment option for trade licences and visa fees. This makes it even more accessible for entrepreneurs around the world to set up and scale up in the UAE.
Kashmala Tariq accident: Islamabad court asks police to verify suspect s license
Pakistan
MNA Kashmala Tariq. File photo
ISLAMABAD: The court hearing a case relating to an accident involving former MNA Kashmala Tariq s son has asked police to verify his driving license, according to Geo News.
Tariq s son, who is the Federal Ombudsperson for Protection against Harassment of Women at the Workplace, was involved in a traffic accident on February 2.
An interim bail hearing of Azlan Shah, Kashmala s son, was held by the District and Sessions Judge Mohammad Sohail. The suspect s lawyer told the court that they had reached an agreement with the relatives of three of the four people killed in the accident.
New Zealand Oil & Gas and partner Beach Energy have applied to relinquish Petroleum Exploration Permit 52717 (Clipper), which contains the Barque prospect.
ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement
ZeClinics is applying CRISPR technology to create gene edited zebrafish disease models
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and ZeClinics, a contract research organization using zebrafish to carry out services focused on analyzing the safety, efficacy and biomedical relevance of new compounds, today announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics CRISPR/Cas9 patent portfolio.
ZeClinics supports academic, pharmaceutical and biotech organizations in pre-clinical studies by providing services based on its zebrafish disease models. The Company is applying CRISPR/Cas9 technology to create single knock-out, double knock-out and somatic F0 knock-out zebrafish variants.